Subscribe
istock-839222794-nicoelnino-1
NicoElnino / iStockphoto.com
17 October 2018Americas

Nestlé and Palette in global urological deal

Nestlé Skin Health and Palette Life Sciences have entered into a global licensing agreement intended to improve outcomes for patients with urological and colorectal disorders.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Nestlé health unit sued over injection technology
15 October 2018   Nestlé’s Skin Health unit has been accused of infringing patents and misappropriating trade secrets relating to neurotoxin and derma filler injections.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Nestlé health unit sued over injection technology
15 October 2018   Nestlé’s Skin Health unit has been accused of infringing patents and misappropriating trade secrets relating to neurotoxin and derma filler injections.

More on this story

Americas
Nestlé health unit sued over injection technology
15 October 2018   Nestlé’s Skin Health unit has been accused of infringing patents and misappropriating trade secrets relating to neurotoxin and derma filler injections.

More features

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims